<?xml version="1.0" encoding="UTF-8"?>
<p>No specific therapeutic medicine has been approved for the treatment of SARS-CoV-2 infection. All patients are given empirical antibiotic or antiviral drugs. Moxifloxacin or levofloxacin are empirically used to treat early coinfections with bacteria [
 <xref rid="B65" ref-type="bibr">65</xref>]. Linezolid is effective against 
 <italic>Streptococcus pneumoniae</italic> and 
 <italic>Staphylococcus aureus</italic> and is combined with nemonoxacin in cases of severe infection [
 <xref rid="B65" ref-type="bibr">65</xref>].
</p>
